Consistent with its tumor-suppressive role, mutations in NOTCH1-4 were significantly associated with a poorer prognosis in the combined cohort (HR 1.67, 95% CI 1.01–2.69, P = 0.046, Fig. 5c). Here, NOTCH1 is linked to neoplasm.